Intuitive Surgical, Inc. (ISRG) EBITDA
- 2026-06-30: Basis Reported; EBITDA (m); Operating income $971.90M; Depreciation and amortization (m).
- 2026-03-31: Basis Reported; EBITDA (m); Operating income $855.30M; Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA (m); Operating income $759.70M; Depreciation and amortization (m).
- 2025-06-30: Basis Reported; EBITDA (m); Operating income $743.40M; Depreciation and amortization (m).
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | Reported | (m) | $971.90M | (m) | $2.89B | (m) | (m) | $1.06B* | $931.90M | $370.60M | $617.90M | $231.40M |
| 2026-03-31 | Reported | (m) | $855.30M | (m) | $2.77B | (m) | (m) | $911.90M | $940.30M | $361.90M | $613.30M | $114.40M |
| 2025-09-30 | Reported | (m) | $759.70M | (m) | $2.51B | (m) | (m) | $841.00M* | $842.70M | $329.40M | $573.30M | $146.00M |
| 2025-06-30 | Reported | (m) | $743.40M | (m) | $2.44B | (m) | (m) | $715.40M* | $822.10M | $313.30M | $561.20M | $167.90M |
| 2025-03-31 | Reported | (m) | $578.10M | (m) | $2.25B | (m) | (m) | $581.60M | $795.70M | $316.20M | $563.40M | -$35.20M |
| 2024-09-30 | Reported | (m) | $577.30M | (m) | $2.04B | (m) | (m) | $706.50M* | $664.20M | $286.00M | $510.60M | $100.40M |
| 2024-06-30 | Reported | (m) | $567.30M | (m) | $2.01B | (m) | (m) | $620.50M* | $637.20M | $280.10M | $525.30M | $123.00M |
| 2024-03-31 | Reported | (m) | $469.40M | (m) | $1.89B | (m) | (m) | $265.40M | $645.20M | $284.50M | $491.50M | -$8.90M |
| 2023-09-30 | Reported | (m) | $465.80M | (m) | $1.74B | (m) | (m) | $548.40M* | $576.50M | $249.40M | $452.00M | $102.20M |
| 2023-06-30 | Reported | (m) | $463.20M | (m) | $1.76B | (m) | (m) | $665.70M* | $584.00M | $244.40M | $464.30M | $73.20M |
| 2023-03-31 | Reported | (m) | $387.60M | (m) | $1.70B | (m) | (m) | $371.40M | $583.20M | $244.90M | $480.50M | $61.00M |
| 2022-09-30 | Reported | (m) | $398.90M | (m) | $1.56B | (m) | (m) | $383.20M* | $505.30M | $217.10M | $436.10M | $78.10M |
| 2022-06-30 | Reported | (m) | $397.60M | (m) | $1.52B | (m) | (m) | $446.70M* | $498.80M | $207.30M | $418.40M | $93.30M |
| 2022-03-31 | Reported | (m) | $408.10M | (m) | $1.49B | (m) | (m) | $223.00M | $478.00M | $210.50M | $391.10M | $33.00M |
| 2021-09-30 | Reported | (m) | $442.60M | (m) | $1.40B | (m) | (m) | $501.40M* | $431.90M | $165.50M | $363.30M | $73.90M |
| 2021-06-30 | Reported | (m) | $511.20M | (m) | $1.46B | (m) | (m) | $542.70M* | $440.30M | $162.30M | $350.20M | $3.20M |
| 2021-03-31 | Reported | (m) | $416.80M | (m) | $1.29B | (m) | (m) | $477.60M | $389.50M | $159.80M | $326.00M | $13.60M |
| 2020-09-30 | Reported | (m) | $270.40M | (m) | $1.08B | (m) | (m) | $274.60M* | $353.40M | $155.00M | $298.90M | $38.40M |
| 2020-06-30 | Reported | (m) | $80.60M | (m) | $852.10M | (m) | (m) | $229.90M* | $349.20M | $143.20M | $279.10M | $37.00M |
| 2020-03-31 | Reported | (m) | $283.00M | (m) | $1.10B | (m) | (m) | $352.80M | $361.30M | $147.10M | $308.10M | -$8.10M |
| 2019-09-30 | Reported | (m) | $365.70M | (m) | $1.13B | (m) | (m) | $396.30M* | $342.60M | $135.90M | $284.00M | $300.00K |
| 2019-06-30 | Reported | (m) | $359.00M | (m) | $1.10B | (m) | (m) | $316.00M* | $339.90M | $120.80M | $279.20M | $75.40M |
| 2019-03-31 | Reported | (m) | $252.20M | (m) | $973.70M | (m) | (m) | $333.20M | $304.10M | $144.00M | $273.40M | -$24.30M |
| 2018-09-30 | Reported | (m) | $313.30M | (m) | $920.90M | (m) | (m) | $319.80M* | $278.60M | $107.60M | $221.40M | $43.40M |
| 2018-06-30 | Reported | (m) | $277.40M | (m) | $909.30M | (m) | (m) | $231.50M* | $277.00M | $95.10M | $259.80M | $41.00M |
| 2018-03-31 | Reported | (m) | $276.70M | (m) | $847.50M | (m) | (m) | $280.20M | $253.70M | $95.50M | $221.60M | $2.60M |
| 2017-09-30 | Reported | (m) | $280.60M | (m) | $807.80M | (m) | (m) | $353.90M* | $239.70M | $83.40M | $204.10M | -$7.20M |
| 2017-06-30 | Reported | (m) | $259.90M | (m) | $758.80M | (m) | (m) | $216.50M* | (m) | $84.60M | $185.60M | $47.00M |
| 2017-03-31 | Reported | (m) | $193.40M | (m) | $679.60M | (m) | (m) | $241.50M | (m) | $73.50M | $202.90M | $21.30M |
| 2016-09-30 | Reported | (m) | $256.40M | (m) | (m) | (m) | (m) | $268.80M* | (m) | $62.60M | $168.00M | $55.80M |
| 2016-06-30 | Reported | (m) | $245.40M | (m) | (m) | (m) | (m) | $261.70M* | (m) | $54.70M | $170.80M | $68.90M |
| 2016-03-31 | Reported | (m) | $179.00M | (m) | (m) | (m) | (m) | $226.80M | (m) | $53.20M | $172.80M | $48.10M |
| 2015-09-30 | Reported | (m) | $189.90M | (m) | (m) | (m) | (m) | $179.70M* | (m) | $51.00M | $154.90M | $29.30M |
| 2015-06-30 | Reported | (m) | $173.80M | (m) | (m) | (m) | (m) | $185.10M* | (m) | $49.40M | $163.30M | $43.90M |
| 2015-03-31 | Reported | (m) | $130.40M | (m) | (m) | (m) | (m) | $123.70M | (m) | $44.40M | $162.00M | $37.70M |
| 2014-09-30 | Reported | (m) | $159.10M | (m) | (m) | (m) | (m) | $150.60M* | (m) | $47.50M | $154.00M | $37.40M |
| 2014-06-30 | Reported | (m) | $143.00M | (m) | (m) | (m) | (m) | $154.00M* | (m) | $40.20M | $161.20M | $38.60M |
| 2014-03-31 | Reported | (m) | $56.60M | (m) | (m) | (m) | (m) | $166.30M | (m) | $43.00M | $215.80M | $16.20M |
| 2013-09-30 | Reported | (m) | $174.20M | (m) | (m) | (m) | (m) | $203.80M* | (m) | $43.20M | $139.30M | $21.30M |
| 2013-06-30 | Reported | (m) | $218.50M | (m) | (m) | (m) | (m) | $189.10M* | (m) | $41.20M | $145.50M | $63.70M |
| 2013-03-31 | Reported | (m) | $251.20M | (m) | (m) | (m) | (m) | $258.00M | (m) | $41.60M | $141.50M | $66.60M |
| 2012-09-30 | Reported | (m) | $211.40M | (m) | (m) | (m) | (m) | $211.60M* | (m) | $49.70M | $129.00M | $32.40M |
| 2012-06-30 | Reported | (m) | $225.30M | (m) | (m) | (m) | (m) | $210.80M* | (m) | $40.20M | $120.90M | $74.40M |
| 2012-03-31 | Reported | (m) | $193.30M | (m) | (m) | (m) | (m) | $165.00M | (m) | $38.40M | $124.20M | $53.60M |
| 2011-09-30 | Reported | (m) | $178.90M | (m) | (m) | (m) | (m) | $157.60M* | (m) | $35.40M | $111.20M | $58.40M |
| 2011-06-30 | Reported | (m) | $168.10M | (m) | (m) | (m) | $33.10M | $200.90M* | (m) | $32.00M | $106.50M | $54.80M |
| 2011-03-31 | Reported | (m) | $148.30M | (m) | (m) | (m) | (m) | $105.40M | (m) | $31.40M | $99.10M | $49.50M |
| 2010-09-30 | Reported | (m) | $132.10M | (m) | (m) | (m) | (m) | $113.00M* | (m) | $26.90M | $91.60M | $50.50M |
| 2010-06-30 | Reported | (m) | $139.70M | (m) | (m) | (m) | (m) | $175.50M* | (m) | $28.50M | $88.60M | $55.50M |
| 2010-03-31 | Reported | (m) | $129.70M | (m) | (m) | (m) | (m) | $115.60M | (m) | $28.00M | $82.80M | $48.50M |
| 2009-09-30 | Reported | (m) | $104.50M | (m) | (m) | (m) | (m) | $96.30M* | (m) | $24.60M | $69.90M | $44.30M |
| 2009-06-30 | Reported | (m) | $99.50M | (m) | (m) | (m) | (m) | $83.00M* | (m) | $23.40M | $67.30M | $42.30M |
| 2009-03-31 | Reported | (m) | $45.00M | (m) | (m) | (m) | (m) | $90.10M | (m) | $21.30M | $62.40M | $21.90M |
| 2008-09-30 | Reported | (m) | $85.03M | (m) | (m) | (m) | (m) | $81.81M* | (m) | $21.85M | $62.69M | $32.03M |
| 2008-06-30 | Reported | (m) | $78.19M | (m) | (m) | (m) | (m) | (m) | (m) | $20.36M | $57.50M | $32.72M |
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | Reported | (m) | $2.95B | (m) | $10.06B | (m) | (m) | $3.03B | $3.42B | $1.31B | $2.38B | $434.80M |
| 2024-12-31 | Reported | (m) | $2.35B | (m) | $8.35B | (m) | (m) | $2.42B | $2.72B | $1.15B | $2.14B | $336.30M |
| 2023-12-31 | Reported | (m) | $1.77B | (m) | $7.12B | (m) | (m) | $1.81B | $2.39B | $998.80M | $1.96B | $141.60M |
| 2022-12-31 | Reported | (m) | $1.58B | (m) | $6.22B | (m) | (m) | $1.49B | $2.03B | $879.00M | $1.74B | $262.40M |
| 2021-12-31 | Reported | (m) | $1.82B | (m) | $5.71B | (m) | (m) | $2.09B | $1.75B | $671.00M | $1.47B | $162.20M |
| 2020-12-31 | Reported | (m) | $1.05B | (m) | $4.36B | (m) | (m) | $1.48B | $1.50B | $595.10M | $1.22B | $140.20M |
| 2019-12-31 | Reported | (m) | $1.37B | (m) | $4.48B | (m) | (m) | $1.60B | $1.37B | $557.30M | $1.18B | $120.40M |
| 2018-12-31 | Reported | (m) | $1.20B | (m) | $3.72B | (m) | (m) | $1.17B | $1.12B | $418.10M | $986.60M | $154.50M |
| 2017-12-31 | Reported | (m) | $1.06B | (m) | $3.14B | (m) | (m) | $1.14B | $936.20M | $328.60M | $810.50M | $433.90M |
| 2016-12-31 | Reported | (m) | $949.70M | (m) | $2.71B | (m) | (m) | $1.09B | $813.60M | $239.60M | $703.60M | $247.00M |
| 2015-12-31 | Reported | (m) | $740.00M | (m) | (m) | (m) | (m) | $806.20M | (m) | $197.40M | $640.50M | $169.70M |
| 2014-12-31 | Reported | (m) | $544.80M | (m) | (m) | (m) | (m) | $665.10M | (m) | $178.00M | $691.00M | $130.20M |
| 2013-12-31 | Reported | (m) | $852.50M | (m) | (m) | (m) | (m) | $880.00M | (m) | $167.70M | $574.00M | $199.90M |
| 2012-12-31 | Reported | (m) | $878.10M | (m) | (m) | (m) | (m) | $814.20M | (m) | $170.00M | $522.20M | $237.30M |
| 2011-12-31 | Reported | (m) | $694.80M | (m) | (m) | (m) | (m) | $677.60M | (m) | $140.20M | $438.80M | $214.60M |
| 2010-12-31 | Reported | (m) | $555.20M | (m) | (m) | (m) | (m) | $545.80M | (m) | $116.00M | $358.80M | $190.50M |
| 2009-12-31 | Reported | (m) | $377.40M | (m) | (m) | (m) | (m) | $392.20M | (m) | $95.10M | $278.60M | $163.50M |
| 2008-12-31 | Reported | (m) | $310.80M | (m) | (m) | (m) | (m) | $278.20M | (m) | $79.40M | $230.60M | $130.90M |
| 2007-12-31 | Reported | (m) | $206.74M | (m) | (m) | (m) | (m) | $205.69M | (m) | $48.86M | $158.69M | $92.70M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Edwards Lifesciences Corp (EW) | United States | $49.409B | 51.96 |
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |